Sangamo Therapeutics, Inc (SGMOQ): Operating Income
-$121.24M
Year ended 2025-12-31
-$123.56M
Trailing 12 months to 2026-03-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$121.24M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$103.97M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$274.00M | n/m | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | -$201.28M | n/m | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | -$183.34M | n/m | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | -$129.55M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$105.18M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$77.15M | n/m | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | -$56.36M | n/m | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | -$72.56M | n/m | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | -$46.86M | n/m | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | -$26.78M | n/m | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | -$26.71M | n/m | 2016-02-18, From 2013-01-01 |
| 2012-12-31 | -$22.20M | n/m | 2015-02-25, From 2012-01-01 |
| 2011-12-31 | -$35.82M | n/m | 2014-02-24, From 2011-01-01 |
| 2010-12-31 | -$24.93M | n/m | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | -$19.40M | n/a | 2012-02-23, From 2009-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Sangamo Therapeutics, Inc (SGMOQ) | 2025-12-31 | -$121.24M | n/m |
| Kymera Therapeutics, Inc. (KYMR) | 2025-12-31 | -$349.40M | n/m |
| Voyager Therapeutics, Inc. (VYGR) | 2025-12-31 | -$131.84M | n/m |
| Editas Medicine, Inc. (EDIT) | 2025-12-31 | -$160.01M | n/m |
| C4 Therapeutics, Inc. (CCCC) | 2025-12-31 | -$115.22M | n/m |
| X4 Pharmaceuticals, Inc (XFOR) | 2025-12-31 | -$86.88M | n/m |
| Fennec Pharmaceuticals Inc. (FENC) | 2025-12-31 | -$6.28M | n/m |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | -$52.15M | n/m |
| Scilex Holding Co (SCLX) | 2025-12-31 | -$346.01M | n/m |
Compare SGMOQ, KYMR, VYGR, EDIT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗